Total reported value
$114.0M
Reporting period: 2020-06-30 · Number of holdings: 4
VV Manager LLC disclosed 4 holdings in its latest 13F filing for the period ending 2020-06-30, with total reported value of $114.0M and a quarterly turnover rate of 38.9%.
Browse other institutions with $100M to $1B AUMBrowse other institutions starting with "V"
Add ALLO
-21.5% $32.5M
Trim 69242L010
0.0% -$4.8M
Trim FIXXEUR
0.0% -$270.0K
Trim STRO
-21.3% -$1.9M
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | ALLO | Allogene Therapeutics INC | Stock-Other | 67.53% | +17.21% | -21.50% | |
| 2 | ✓ | Oyster Point Pharma, INC. | Stock-Other | 19.72% | -11.07% | — | |
| 3 | FIXXEUR | Homology Medicines INC | Stock-Other | 10.27% | -3.27% | — | |
| 4 | STRO | Sutro Biopharma, Inc. | Stock-Other | 2.49% | -2.87% | -21.34% |
Not enough priced holdings yet to compute performance
Not enough sector-mapped data yet
| Period | Holdings | Total value | Stability | Top holdings |
|---|---|---|---|---|
| 2020-06-30 | 4 | $114.0M | 39 | |
| 2020-03-31 | 4 | $88.5M | 86 | |
| 2019-12-31 | 4 | $125.5M | 49 | |
| 2019-09-30 | 3 | $134.4M | 31 | |
| 2019-06-30 | 3 | $184.4M | 32 | |
| 2019-03-31 | 3 | $254.8M | 9 | |
| 2018-12-31 | 3 | $233.1M | 0 |
VV Manager LLC's most significant position changes for 2020-06-30: Trim: Allogene Therapeutics INC (ALLO) — shares -21.50%; Trim: Sutro Biopharma, Inc. (STRO) — shares -21.34%.
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | ALLO | Allogene Therapeutics INC | +17.2% | -21.50% | Trim |
| 2 | STRO | Sutro Biopharma, Inc. | -2.9% | -21.34% | Trim |
| 3 | FIXXEUR | Homology Medicines INC | -3.3% | — | Unchanged |
| 4 | ✓ | Oyster Point Pharma, INC. | -11.1% | — | Unchanged |
Institutions with a similar AUM
CIK 0001829271
Total reported value
$114.0M
196 stks
2026-03-31
AUM within 0.0% of this institution
CIK 0002045252
Total reported value
$114.0M
282 stks
2026-03-31
AUM within 0.0% of this institution
CIK 0002035215
Total reported value
$114.1M
797 stks
2026-03-31
AUM within 0.1% of this institution
Institutions with overlapping top holdings
CIK 0000078003
Total reported value
$238.8M
21 stks
2026-03-31
1 of the top 5 holdings overlap, including Allogene Therapeutics INC
CIK 0001495741
Total reported value
$10.1B
51 stks
2021-09-30
Stale — no recent filing
1 of the top 5 holdings overlap, including Allogene Therapeutics INC
CIK 0001582384
Total reported value
$106.2M
2 stks
2026-03-31
1 of the top 5 holdings overlap, including Allogene Therapeutics INC